193 related articles for article (PubMed ID: 26625716)
1. Dual strategies to improve oral bioavailability of oleanolic acid: Enhancing water-solubility, permeability and inhibiting cytochrome P450 isozymes.
Jiang Q; Yang X; Du P; Zhang H; Zhang T
Eur J Pharm Biopharm; 2016 Feb; 99():65-72. PubMed ID: 26625716
[TBL] [Abstract][Full Text] [Related]
2. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
3. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
4. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles.
Xia X; Liu H; Lv H; Zhang J; Zhou J; Zhao Z
Drug Des Devel Ther; 2017; 11():1417-1427. PubMed ID: 28533680
[TBL] [Abstract][Full Text] [Related]
6. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo comparison of T-OA microemulsions and solid dispersions based on EPDC.
Hou P; Cao S; Ni J; Zhang T; Cai Z; Liu J; Wang Y; Wang P; Lei H; Liu Y
Drug Dev Ind Pharm; 2015 Feb; 41(2):263-71. PubMed ID: 24256156
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Liu Y; Luo X; Xu X; Gao N; Liu X
Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
10. Improving permeability and oral absorption of mangiferin by phospholipid complexation.
Ma H; Chen H; Sun L; Tong L; Zhang T
Fitoterapia; 2014 Mar; 93():54-61. PubMed ID: 24220727
[TBL] [Abstract][Full Text] [Related]
11. Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods.
Guo B; Liu H; Li Y; Zhao J; Yang D; Wang X; Zhang T
Int J Pharm; 2014 Oct; 474(1-2):50-6. PubMed ID: 25108049
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of a novel solid dispersion using leucine as carrier.
Xia X; Tan Z; Fan Y; Hu Y; Deng J
J Pharm Pharmacol; 2020 Feb; 72(2):175-184. PubMed ID: 31846087
[TBL] [Abstract][Full Text] [Related]
13. Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.
Wang W; Zhang W; Jiang Y; Wang X; Zhang X; Liu H; Zhang T
Pharm Dev Technol; 2020 Jan; 25(1):68-75. PubMed ID: 31544585
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Intestinal Absorption and Bioavailability of a Bergenin-Phospholipid Complex Solid Dispersion in Rats.
Gao H; Wei Y; Xi L; Sun Y; Zhang T
AAPS PharmSciTech; 2018 May; 19(4):1720-1729. PubMed ID: 29556829
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats.
Kageyama M; Namiki H; Fukushima H; Ito Y; Shibata N; Takada K
Biol Pharm Bull; 2005 Feb; 28(2):316-22. PubMed ID: 15684491
[TBL] [Abstract][Full Text] [Related]
16. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid complex as an approach for bioavailability enhancement of echinacoside.
Li F; Yang X; Yang Y; Li P; Yang Z; Zhang C
Drug Dev Ind Pharm; 2015; 41(11):1777-84. PubMed ID: 25686726
[TBL] [Abstract][Full Text] [Related]
18. Use of acidifier and solubilizer in tadalafil solid dispersion to enhance the in vitro dissolution and oral bioavailability in rats.
Choi JS; Kwon SH; Lee SE; Jang WS; Byeon JC; Jeong HM; Park JS
Int J Pharm; 2017 Jun; 526(1-2):77-87. PubMed ID: 28450170
[TBL] [Abstract][Full Text] [Related]
19. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
20. Solubility and Permeability Enhancement of Oleanolic Acid by Solid Dispersion in Poloxamers and γ-CD.
De Stefani C; Lodovichi J; Albonetti L; Salvatici MC; Quintela JC; Bilia AR; Bergonzi MC
Molecules; 2022 May; 27(9):. PubMed ID: 35566392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
